Assembly Biosciences Inc.

NASDAQ: ASMB · Real-Time Price · USD
25.29
0.33 (1.32%)
At close: Aug 15, 2025, 3:59 PM
25.50
0.85%
After-hours: Aug 15, 2025, 07:52 PM EDT

Assembly Biosciences Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Cash & Equivalents
24.01M 23.41M 38.34M 28.45M 19.21M 18.75M 19.84M 26.66M 21.62M 43.48M 52.42M 54.67M 43.06M 51.17M 45.63M 70.76M 59.52M 78.25M
Short-Term Investments
50.97M 67.61M 73.73M 66.5M 90.01M 94.23M 110.41M 19.55M 38.21M 29.53M 39.19M 53.98M 73.63M 71.83M 101M 110.14M 139.56M 136.63M
Long-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 11.91M 23.46M 27.97M 9.18M n/a n/a
Other Long-Term Assets
312K 312K 312K 312K 312K 312K 312K 552K 332K 334K 78K 1.61M 1.64M 2.17M 1.7M 1.92M 6.09M 6.03M
Receivables
n/a n/a n/a n/a n/a 43K 43K n/a 342K 717K 944K 1.25M 523K 524K 336K 769K 297K 203K
Inventory
n/a n/a n/a n/a n/a n/a n/a -100K n/a n/a n/a n/a 0.00 n/a n/a n/a n/a n/a
Other Current Assets
2.49M 4.5M 3.42M 3.26M 3.71M 4.15M 3.5M 3.46M 3.91M n/a 4.41M 5.18M 7.08M n/a 7.24M 6.55M 6.18M 6.55M
Total Current Assets
77.47M 95.53M 115.5M 98.21M 112.93M 117.17M 133.79M 49.67M 64.08M 79.74M 96.97M 115.08M 124.29M 130.78M 154.2M 188.22M 205.56M 221.63M
Property-Plant & Equipment
3M 3.18M 3.35M 1.74M 2.08M 2.4M 2.72M 1.41M 2.16M 3.04M 3.94M 4.83M 5.61M 6.32M 7.18M 8.01M 8.85M 9.6M
Goodwill & Intangibles
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -1.54M 41.64M 41.64M 41.64M
Total Long-Term Assets
3.31M 3.49M 3.67M 2.05M 2.39M 2.71M 3.68M 1.96M 2.5M 3.37M 4.83M 6.44M 19.15M 31.95M 36.86M 60.75M 56.58M 57.27M
Total Assets
80.78M 99.02M 119.17M 100.26M 115.32M 119.88M 137.47M 51.63M 66.58M 83.12M 101.79M 121.52M 143.45M 162.73M 191.06M 248.97M 262.14M 278.9M
Account Payables
743K 875K 585K 1.33M 801K 727K 461K 758K 904K 1.22M 2.49M 1.94M 2.45M 1.41M 2.66M 2.63M 2.87M 3.56M
Deferred Revenue
40.92M 40.82M 37.62M 32.62M 33.06M 32.77M 30.91M 2.73M 2.73M 2.73M 2.73M 2.73M 2.73M 2.73M 2.73M 2.73M 8.99M 8.99M
Short-Term Debt
533K n/a n/a n/a 1.29M 1.15M n/a 869K 1.7M 2.55M n/a 3.37M 3.31M 3.21M n/a 3.1M 3.05M 2.93M
Other Current Liabilities
5.1M 1.82M 6.48M 6.35M 2.03M 1.24M 1.15M 2.87M 2.21M 1.16M 4.21M 2.71M 1.48M 727K n/a 1.77M 1.89M 3.23M
Total Current Liabilities
47.29M 46.63M 47.8M 41.63M 41.27M 38.75M 39.23M 7.13M 8.83M 9.97M 16.3M 15.46M 14.96M 10.71M 16.07M 14.93M 13.91M 14.5M
Long-Term Debt
2.35M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Liabilities
13.04M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Liabilities
15.39M 25.25M 38.01M 32.62M 39.37M 48.53M 57.15M 2.78M 2.8M 2.81M 2.83M 3.65M 4.51M 5.23M 6.06M 9.4M 16.43M 17.16M
Total Liabilities
62.68M 71.88M 85.81M 74.26M 80.64M 87.28M 96.37M 9.91M 11.63M 12.78M 19.13M 19.11M 19.47M 15.94M 22.13M 24.33M 30.34M 31.66M
Total Debt
2.88M 3.02M 3.09M 1.44M 1.75M 1.94M 2.34M 919K 1.77M 2.63M 3.46M 4.29M 5.08M 5.7M 6.48M 7.24M 7.96M 8.58M
Common Stock
8K 8K 7K 6K 6K 5K 5K 53K 52K 52K 49K 48K 48K 48K 48K 47K 44K 40K
Retained Earnings
-844.94M -834.74M -825.92M -815.59M -805.98M -794.83M -785.75M -774.79M -760.37M -743.47M -724.52M -702.13M -678.98M -654.52M -631.43M -571.17M -552.37M -528.77M
Comprehensive Income
-279K -253K -211K -156K -293K -239K -81K -275K -325K -513K -803K -999K -998K -908K -419K -288K -273K -271K
Shareholders Equity
18.1M 27.13M 33.36M 26M 34.68M 32.6M 41.1M 41.71M 54.95M 70.33M 82.66M 102.4M 123.98M 146.79M 168.93M 224.65M 231.79M 247.24M
Total Investments
n/a 67.61M 73.73M 66.5M 90.01M 94.23M 110.41M 19.55M 38.21M 29.53M 39.19M 53.98M 85.53M 95.28M 101M 119.32M 139.56M 136.63M